Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
The current pandemic coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) calls urgently for effective therapies. Anti-malarial medicine chloroquine (CQ) and particularly its chemical analogue hydroxychloroquine (HCQ) have been recommended as...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2020-01-01
|
| シリーズ: | Emerging Microbes and Infections |
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/22221751.2020.1760145 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|